Combining COVID-19 and seasonal influenza vaccines together to increase the acceptance of newly developed vaccines in the Eastern Mediterranean Region: a cross-sectional study

References

• WHO. Coronavirus disease (COVID-19) dashboard with vaccination data [Internet]. Geneva (Switzerland): World Health Organization; 2022 [cited 2023 May 27]. Available from: https://covid19.who.int/
   Google Scholar
• WHO. Coronavirus disease (COVID-19): vaccines [Internet]. Geneva (Switzerland): World Health Organization; 2020 [cited 2023 Oct 18]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-vaccines?adgroupsurvey=%7Badgroupsurvey%7D&gclid=CjwKCAjw1MajBhAcEiwAagW9MaLVQh5W4YnEk21jItVQYk_3Phcn0iHGLSIeljt938kvaK7uFca
   Google Scholar
• Moriyama M, Hugentobler WJ, Iwasaki A. Seasonality of respiratory viral infections. Annu Rev Virol. 2020;7(1):1–14. doi: 10.1146/annurev-virology-012420-022445.
   PubMedGoogle Scholar
• WHO. Global influenza programme [Internet]. Geneva (Switzerland): World Health Organization; 2017 [cited 2023 Oct 18]. Available from: https://www.who.int/teams/global-influenza-programme/surveillance-and-monitoring/burden-of-disease
   Google Scholar
• Schmitt BD. Influenza, seasonal. In: American Academy of Pediatrics, editor. My child is sick! 2nd ed. [Internet]. Geneva (Switzerland): World Health Organization; 2021. p. 195–205 [cited 2023 May 27]. Available from: https://www.who.int/health-topics/influenza-seasonal#tab=tab_1
   Google Scholar
• Centers for Disease Control and Prevention. Influenza vaccinations administered in pharmacies and physician medical offices, adults, United States [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2021 [cited 2023 Oct 18]. Available from: https://www.cdc.gov/flu/fluvaxview/dashboard/vaccination-administered.html
   Google Scholar
• Santibanez TA, Srivastav A, Zhai Y, et al. Trends in childhood influenza vaccination coverage, United States, 2012–2019. Public Health Rep. 2020;135(5):640–649. doi: 10.1177/0033354920944867.
   PubMed Web of Science ®Google Scholar
• Al Awaidy ST, Ghazy RM, Mahomed O, et al. The impact of non-pharmaceutical interventions (NPIs) on communicable diseases. Front Public Health. 2023;11:1270709. doi: 10.3389/fpubh.2023.1270709.
   PubMed Web of Science ®Google Scholar
• Daniels RS, McCauley JW. The health of influenza surveillance and pandemic preparedness in the wake of the COVID-19 pandemic. J Gen Virol. 2023;104(2):001822.
   Web of Science ®Google Scholar
• WHO. Coadministration of seasonal inactivated influenza and COVID-19 vaccines: interim guidance. Geneva (Switzerland): World Health Organization; 2021 [cited 2023 Oct 18]. Available from: https://iris.who.int/bitstream/handle/10665/346897/WHO-2019-nCoV-SAGE-Vaccines-coadministration-Influenza-2021.1-eng.pdf
   Google Scholar
• Dadashi M, Khaleghnejad S, Abedi Elkhichi P, et al. COVID-19 and influenza co-infection: a systematic review and meta-analysis. Front Med (Lausanne). 2021;8:681469. doi: 10.3389/fmed.2021.681469.
   PubMed Web of Science ®Google Scholar
• Arokiaraj MC. Correlation of influenza vaccination and influenza incidence on COVID-19 severity and other perspectives. SSRN Electron J. 2020;86:1–37.
   Google Scholar
• Fink G, Orlova-Fink N, Schindler T, et al. Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil. BMJ Evid Based Med. 2021;26(4):192–193. doi: 10.1136/bmjebm-2020-111549.
   Google Scholar
• Focosi D. From co-administration to co-formulation: the race for new vaccines against COVID-19 and other respiratory viruses. Vaccines (Basel). 2023;11(1):109. doi: 10.3390/vaccines11010109.
   PubMed Web of Science ®Google Scholar
• Massare MJ, Patel N, Zhou B, et al. Combination respiratory vaccine containing recombinant SARS-CoV-2 spike and quadrivalent seasonal influenza hemagglutinin nanoparticles with matrix-m adjuvant. bioRxiv. 2021. doi: 10.1101/2021.05.05.442782.
   Google Scholar
• Pfizer. Pfizer and BioNTech initiate phase 1 study of single dose mRNA-based combination vaccine candidate for influenza and COVID-19 [Internet]. New York (NY): Pfizer; 2022 [cited 2023 Oct 18]. Available from: https://www.pfizer.com/news/announcements/pfizer-and-biontech-initiate-phase-1-study-single-dose-mrna-based-combination
   Google Scholar
• MacDonald NE, SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4164. doi: 10.1016/j.vaccine.2015.04.036.
   PubMed Web of Science ®Google Scholar
• Bonanni P, Boccalini S, Bechini A, et al. Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines. Hum Vaccin Immunother. 2020;16(6):1313–1321. doi: 10.1080/21645515.2019.1688032.
   PubMed Web of Science ®Google Scholar
• Domnich A, Grassi R, Fallani E, et al. Acceptance of COVID-19 and influenza vaccine co-administration: insights from a representative Italian survey. J Pers Med. 2022;12(2):139. doi: 10.3390/jpm12020139.
   PubMed Web of Science ®Google Scholar
• Maas CJM, Hox JJ. Sufficient sample sizes for multilevel modeling. Methodology. 2005;1(3):86–92. doi: 10.1027/1614-2241.1.3.86.
   Google Scholar
• Moineddin R, Matheson FI, Glazier RH. A simulation study of sample size for multilevel logistic regression models. BMC Med Res Methodol. 2007;7(1):34. doi: 10.1186/1471-2288-7-34.
   PubMedGoogle Scholar
• International Labour Organization. International Standard Classification of Occupations 2008 (ISCO-08): structure, group definitions and correspondence tables. Geneva (Switzerland): International Labour Organization; 2012. Available from: https://www.ilo.org/wcmsp5/groups/public/–-dgreports/–-dcomm/–-publ/documents/publication/wcms_172572.pdf
   Google Scholar
• CDC. About chronic diseases [Internet]. Atlanta (GA): National Center for Chronic Disease Prevention and Health Promotion, CDC; 2022 [cited 2023 Oct 18]. Available from: https://www.cdc.gov/chronicdisease/about/index.htm#:∼:text=Chronic%20diseases%20are%20defined%20broadly,disability%20in%20the%20United%20States
   Google Scholar
• Ashcroft R. The Declaration of Helsinki. In: Emanuel EJ, Grady C, Crouch RA, Lie RK, Miller FG, Wendler D, editors. The Oxford textbook of clinical research ethics. New York (NY): Oxford University Press; 2008. p. 141–148.
   Google Scholar
• Bates D, Mächler M, Bolker B, et al. Fitting linear mixed-effects models using lme4. J Stat Softw 2015;67(1):1–48.
   Web of Science ®Google Scholar
• Sommet N, Morselli D. Keep calm and learn multilevel logistic modeling: a simplified three-step procedure using Stata, R, Mplus, and SPSS. Int Rev Soc Psychol. 2017;30(1):203–218. doi: 10.5334/irsp.90.
   Web of Science ®Google Scholar
• Finch WH, Bolin JH, Kelley K. Multilevel modeling using R. New York (NY): CRC Press; 2019.
   Google Scholar
• Xie Z, Hamadi HY, Mainous AG, et al. Association of dual COVID-19 and seasonal influenza vaccination with COVID-19 infection and disease severity. Vaccine. 2023;41(4):875–878. doi: 10.1016/j.vaccine.2022.12.043.
   PubMed Web of Science ®Google Scholar
• Palache A, Oriol-Mathieu V, Abelin A, et al. Seasonal influenza vaccine dose distribution in 157 countries (2004–2011). Vaccine. 2014;32(48):6369–6376. doi: 10.1016/j.vaccine.2014.07.012.
   PubMed Web of Science ®Google Scholar
• Al Awaidi S, Abusrewil S, AbuHasan M, et al. Influenza vaccination situation in Middle-East and North Africa countries: report of the 7th MENA Influenza Stakeholders Network (MENA-ISN). J Infect Public Health. 2018;11(6):845–850. doi: 10.1016/j.jiph.2018.07.003.
   PubMed Web of Science ®Google Scholar
• Ahmed WS, Abu Farha R, Halboup AM, et al. Knowledge, attitudes, perceptions, and practice toward seasonal influenza and its vaccine: a cross-sectional study from a country of conflict. Front Public Health. 2023;11:1030391.
   PubMedGoogle Scholar
• Ghazy RM, Sallam M, Abdullah FSA, et al. The effect of combining the COVID-19 vaccine with the seasonal influenza vaccine on reducing COVID-19 vaccine rejection among Libyans. J Epidemiol Glob Health. 2023;13(2):292–302. doi: 10.1007/s44197-023-00107-2.
   PubMed Web of Science ®Google Scholar
• Ghazy RM, Ibrahim SA, Taha SH, et al. Attitudes of parents towards influenza vaccine in the Eastern Mediterranean Region: a multilevel analysis. Vaccine. 2023;41(36):5253–5264. doi: 10.1016/j.vaccine.2023.07.005.
   PubMed Web of Science ®Google Scholar
• Elbarazi I, Yacoub M, Reyad OA, et al. Exploring enablers and barriers toward COVID-19 vaccine acceptance among Arabs: a qualitative study. Int J Disaster Risk Reduct. 2022;82:103304. doi: 10.1016/j.ijdrr.2022.103304.
   PubMed Web of Science ®Google Scholar
• Abdelmoneim SA, Sallam M, Hafez DM, et al. COVID-19 vaccine booster dose acceptance: systematic review and meta-analysis. Trop Med Infect Dis. 2022;7(10):298. doi: 10.3390/tropicalmed7100298.
   PubMedGoogle Scholar
• Lennon RP, Block R, Schneider EC, et al. Underserved population acceptance of combination influenza-COVID-19 booster vaccines. Vaccine. 2022;40(4):562–567. doi: 10.1016/j.vaccine.2021.11.097.
   PubMed Web of Science ®Google Scholar
• Lin XQ, Zhang MX, Chen Y, et al. Relationship between knowledge, attitudes, and practices and COVID-19 vaccine hesitancy: a cross-sectional study in Taizhou, China. Front Med (Lausanne). 2022;9:770933. doi: 10.3389/fmed.2022.770933.
   PubMed Web of Science ®Google Scholar
• Abrina GN, Abrina JF, Abrina GN. Acceptance of COVID-19 vaccine among the people of Al-Jabal Al-Akhdar district in Libya as of April 2021. Asian J Basic Sci Res. 2021;3(3):47–57. 3(3):doi: 10.38177/AJBSR.2021.3306.
   Google Scholar
• Ha GL, Block R, Gillespie S, et al. Lack of trust appears to drive “racial” differences in COVID-19 vaccine confidence. Ann Behav Med. 2022;56(SUPP 1):S315.
   Web of Science ®Google Scholar
• Buzgeia AM, Abdrabba FA. Acceptance of COVID-19 vaccine among general population and students in Benghazi, Libya: a cross sectional study. Education. 2021;139(101):57–59.
   Google Scholar
• Dadras O, SeyedAlinaghi S, Karimi A, et al. Public acceptability of COVID-19 vaccines and its predictors in Middle Eastern/North African (MENA) countries: a systematic review. Hum Vaccin Immunother. 2022;18(5):2043719.
   PubMed Web of Science ®Google Scholar
• Atrooz F, Majd Z, Alrousan G, et al. Acceptance of COVID-19 vaccination in a sample of Middle Eastern and North African (MENA) Houston residents. PLOS Glob Public Health. 2023;3(2):e0001441. doi: 10.1371/journal.pgph.0001441.
   PubMedGoogle Scholar
• Shakeel CS, Mujeeb AA, Mirza MS, et al. Global COVID-19 vaccine acceptance: a systematic review of associated social and behavioral factors. Vaccines (Basel). 2022;10(1):110. doi: 10.3390/vaccines10010110.
   PubMed Web of Science ®Google Scholar
• Our World in Data. Coronavirus (COVID-19) vaccinations [Internet]. Oxford (UK): Our World in Data; 2023 [cited 2023 May 27]. Available from: https://ourworldindata.org/covid-vaccinations?country
   Google Scholar
• Solís Arce JS, Warren SS, Meriggi NF, et al. COVID-19 vaccine acceptance and hesitancy in low-and middle-income countries. Nat Med. 2021;27(8):1385–1394. doi: 10.1038/s41591-021-01454-y.
   PubMed Web of Science ®Google Scholar
• WHO. Behavioural and social drivers of vaccination: tools and practical guidance for achieving high uptake [Internet]. Geneva (Switzerland): World Health Organization; 2022 [cited 2023 Oct 18]. Available from: https://apps.who.int/iris/handle/10665/354459
   Google Scholar
• Tzenios N, Tazanios ME, Chahine M. Combining influenza and COVID-19 booster vaccination strategy to improve vaccination uptake necessary for managing the health pandemic: a systematic review and meta-analysis. Vaccines (Basel). 2022;11(1):16. doi: 10.3390/vaccines11010016.
   PubMed Web of Science ®Google Scholar